Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)
Taiwan · Delayed Price · Currency is TWD 19.20
+0.40 (2.13%)
Aug 26, 2026, 1:54 PM CST
TPEX:6704 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 157.86 | 187.02 | 170.03 | 141.18 | 180.67 | 242.75 | |
Revenue Growth | -14.63% | 10.00% | 20.44% | -21.86% | -25.57% | 28.75% |
Cost of Revenue | 45.38 | 55.05 | 53.38 | 44.4 | 25.86 | 45.68 |
Gross Profit | 112.48 | 131.97 | 116.64 | 96.77 | 154.81 | 197.07 |
Selling, General & Admin | 97.4 | 90.14 | 81.91 | 82.78 | 160.54 | 203.38 |
Research & Development | 107.26 | 115.5 | 110.67 | 108.17 | 109.16 | 95.11 |
Operating Expenses | 204.62 | 205.64 | 192.58 | 190.73 | 270.1 | 296.49 |
Operating Income | -92.15 | -73.67 | -75.93 | -93.96 | -115.29 | -99.42 |
Interest Expense | -9.94 | -9.83 | -11.43 | -12.36 | -1.96 | -1.67 |
Interest & Investment Income | 2.4 | 2.91 | 3.92 | 1.62 | 0.26 | 0.07 |
Currency Exchange Gain (Loss) | - | - | - | -0.02 | 0.05 | -0.03 |
Other Non Operating Income (Expenses) | 0.68 | 0.07 | 0.14 | 1.69 | 0.94 | 3.23 |
EBT Excluding Unusual Items | -99.02 | -80.52 | -83.31 | -103.03 | -116 | -97.83 |
Gain (Loss) on Sale of Assets | - | - | - | 15.88 | 4.86 | - |
Other Unusual Items | - | - | - | - | 0.21 | 0.89 |
Pretax Income | -99.02 | -80.52 | -83.31 | -87.15 | -110.94 | -96.94 |
Income Tax Expense | 0.02 | - | 0.01 | 0.94 | 0.68 | 5.81 |
Earnings From Continuing Operations | -99.04 | -80.52 | -83.32 | -88.09 | -111.61 | -102.74 |
Minority Interest in Earnings | - | - | - | - | -0.49 | -3.5 |
Net Income | -99.04 | -80.52 | -83.32 | -88.09 | -112.11 | -106.24 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.69 |
Net Income to Common | -99.04 | -80.52 | -83.32 | -88.09 | -112.11 | -106.93 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 95 | 96 | 96 | 90 | 85 | 83 |
Shares Outstanding (Diluted) | 95 | 96 | 96 | 90 | 85 | 83 |
Shares Change | -1.41% | - | 7.12% | 4.86% | 3.04% | 2.86% |
EPS (Basic) | -1.04 | -0.84 | -0.87 | -0.98 | -1.31 | -1.29 |
EPS (Diluted) | -1.04 | -0.84 | -0.87 | -0.98 | -1.31 | -1.29 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -69.37 | -80.72 | -75.3 | -17.79 | -81.88 | -72.34 |
Free Cash Flow Per Share | -0.73 | -0.84 | -0.79 | -0.20 | -0.96 | -0.87 |
Gross Margin | 71.25% | 70.56% | 68.60% | 68.55% | 85.69% | 81.18% |
Operating Margin | -58.37% | -39.39% | -44.66% | -66.55% | -63.81% | -40.96% |
Profit Margin | -62.74% | -43.05% | -49.00% | -62.40% | -62.05% | -44.05% |
Free Cash Flow Margin | -43.95% | -43.16% | -44.28% | -12.60% | -45.32% | -29.80% |
EBITDA | -37.29 | -21.22 | -23.4 | -41.3 | -64.45 | -74.74 |
EBITDA Margin | -23.62% | -11.35% | -13.76% | -29.25% | -35.67% | -30.79% |
D&A For EBITDA | 54.85 | 52.45 | 52.53 | 52.66 | 50.84 | 24.68 |
EBIT | -92.15 | -73.67 | -75.93 | -93.96 | -115.29 | -99.42 |
EBIT Margin | -58.37% | -39.39% | -44.66% | -66.55% | -63.81% | -40.96% |